Catamaran Achieves Five-Star Medication Safety Ratings, Drives Improved Health Outcomes
LISLE, IL, May 30, 2013 /PRNewswire/ - Catamaran Corp. (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management (PBM) services and technology, today announced it has received a 2013 PQA Quality Award recognizing its five-star rating on all PQA measures in the Part D Star Ratings program.
The award is administered by Pharmacy Quality Alliance (PQA), an organization dedicated to improving patient health by championing clear performance measures for medication management, and recognizes those organizations that foster exceptional pharmacy quality.
"We are honored to be recognized by PQA for our commitment to continuously enhancing the quality of care in the Medicare arena," said Mark Thierer, Chairman and Chief Executive Officer of Catamaran. "By leveraging our resources, skill, and scale, Catamaran has achieved powerful results in improving health outcomes and reducing costs, all with a laser-sharp focus on patient safety."
PQA's recognition program for prescription drug plans recognizes Medicare prescription drug plans (both MA-PD and PDP) that have demonstrated outstanding performance in medication-related quality as determined through the use of publicly-available performance data for Medicare Part D.
"Catamaran Corporation has achieved industry-leading safety scores in the care of its Medicare members, meeting PQA's standards of excellence for this year's Quality Recognition Award," said Laura Cranston, PQA's Executive Director. "Catamaran serves as a model for the high outcomes that are possible when innovation and commitment come together across an organization."
The award was formally presented at PQA's annual meeting and luncheon on May 29, 2013. This is the third year the consensus-based, multi-stakeholder organization provided this unique recognition to top healthcare providers administrating Medicare prescription services across the nation.
There are five PQA-endorsed quality measures that are used within the CMS' Medicare Star Ratings program. Details on these measures are available at the PQA website: www.PQAalliance.org
Catamaran, the industry's fastest-growing pharmacy benefits manager, helps organizations and the communities they serve take control of prescription drug costs. Managing more than 250 million prescriptions each year on behalf of 25 million members, our flexible, holistic solutions improve patient care and empower individuals to take charge of their health. Processing one in every five prescription claims in the U.S., Catamaran's skill and scale deliver compelling financial results and sustainable improvement in the overall health of members. Catamaran is headquartered in Lisle, Ill. with multiple locations in the U.S. and Canada. For more information, please visit www.catamaranRx.com.
Established in 2006, PQA represents pharmacy providers, pharmacy benefit managers, health plans, academicians, consumer advocates, employers, pharmaceutical research and manufacturing companies, and other stakeholders interested in improving the quality of the medication-use system. PQA's mission is to: Improve the quality of medication management and use across health care settings with the goal of improving patients' health through a collaborative process to develop and implement performance measures and recognize examples of exceptional pharmacy quality.
PQA provides a leadership role in identification and selection of metrics for evaluation of the quality of the medication-use system, provides education on quality improvement, and connects pharmacists to healthcare improvement initiatives.